Yuyu Pharma, Inc. (KRX:000220)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,305.00
-30.00 (-0.69%)
Mar 18, 2026, 3:30 PM KST

Yuyu Pharma Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
67,79372,90385,445102,750130,082108,199
Market Cap Growth
-8.33%-14.68%-16.84%-21.01%20.23%62.16%
Enterprise Value
81,64576,861119,950114,352120,293117,748
Last Close Price
4305.004391.645032.115927.987320.646750.25
PE Ratio
14.959.62---108.35
PS Ratio
0.490.550.620.741.131.10
PB Ratio
0.490.540.710.831.010.92
P/TBV Ratio
0.550.610.810.931.110.99
P/FCF Ratio
26.354.09----
P/OCF Ratio
7.552.92203.03-28.85-
EV/Sales Ratio
0.590.580.870.821.041.20
EV/EBITDA Ratio
4.854.2124.6925.7821.0911.58
EV/EBIT Ratio
7.296.11--100.2318.78
EV/FCF Ratio
31.734.31----
Debt / Equity Ratio
0.210.250.330.320.300.17
Debt / EBITDA Ratio
1.751.848.118.866.871.96
Debt / FCF Ratio
11.251.89----
Net Debt / Equity Ratio
0.00-0.070.060.07-0.090.00
Net Debt / EBITDA Ratio
0.02-0.491.451.92-1.95-0.05
Net Debt / FCF Ratio
0.11-0.50-1.72-0.747.090.04
Asset Turnover
0.690.660.700.720.670.67
Inventory Turnover
2.001.982.112.642.892.60
Quick Ratio
0.920.971.140.862.432.20
Current Ratio
1.771.582.031.503.303.50
Return on Equity (ROE)
5.40%8.06%-4.55%-3.51%-0.75%2.32%
Return on Assets (ROA)
3.37%3.88%-0.24%-0.19%0.43%2.68%
Return on Invested Capital (ROIC)
7.80%9.93%-0.58%-0.47%1.03%3.94%
Return on Capital Employed (ROCE)
7.40%8.80%-0.50%-0.50%0.70%4.60%
Earnings Yield
7.21%11.96%-8.40%-5.83%-1.70%1.19%
FCF Yield
3.79%24.47%-4.79%-11.20%-1.20%-13.60%
Dividend Yield
2.31%2.28%----
Payout Ratio
31.97%----118.38%
Buyback Yield / Dilution
-9.19%-3.29%1.89%-3.90%-32.81%19.87%
Total Shareholder Return
-6.87%-1.02%1.89%-3.90%-32.81%19.87%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.